Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
17
-
Total 13F principal, excl. options
-
199,553,764
-
Principal change
-
+199,553,764
-
Total reported value, excl. options
-
$115,520,638
-
Value change
-
+$115,520,638
-
Number of buys
-
17
-
Price
-
$0.5275
Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2021
17 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2021.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $199,553,764 of principal
.
Largest 10 bondholders include Pentwater Capital Management LP ($46,411,000 of principal), LAZARD ASSET MANAGEMENT LLC ($24,300,000 of principal), Davidson Kempner Capital Management LP ($24,000,000 of principal), WHITEBOX ADVISORS LLC ($22,500,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($20,000,000 of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($17,590,000 of principal), AMERIPRISE FINANCIAL INC ($16,100,000 of principal), MORGAN STANLEY ($7,046,000 of principal), Point72 Asset Management, L.P. ($7,000,000 of principal), and BlueCrest Capital Management Ltd ($7,000,000 of principal).
This table shows the top 17 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.